<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1807222312
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1992
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NO-URIC TAB 300MG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALLOPURINOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        300
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="EIPICO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            EIPICO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 449]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Khalid Bin Saad Int. Company LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            EIPICO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M04AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>No-Uric tablets contain a medicine called allopurinol. It works by slowing down the speed of certain chemical reactions in your body.</p><p>No-Uric is used:</p><p>- To prevent gout. This is a disease where your body produces too much of a substance called &#39;uric acid&#39;. The uric acid builds up in your joints and tendons as crystals. These crystals cause an inflammatory reaction. The inflammation causes the skin around certain joints to become swollen, tender and sore when only slightly touched. You can also find you get severe pain when the joint is moved.</p><p>- To prevent other conditions where there is a build up of uric acid in the body. These include kidney stones and certain other types of kidney problem and when you are having treatment for cancer.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take No-Uric if:</p><p>- You are allergic (hypersensitive) to allopurinol or to any of the other ingredients in No-Uric.</p><p>Do not take No-Uric if the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking No-Uric.</p><p>Take special care with No-Uric:</p><p>Check with your doctor or pharmacist before taking your medicine if:</p><p>-You have problems with your liver or kidneys. Your doctor may give you a lower dose or ask you to take it less often than each day. They will also monitor you more closely.</p><p>- You have heart problems or high blood pressure.</p><p>- You are currently having an attack of gout.</p><p>- You have been told by your doctor that you have an intolerance to lactose. No-Uric tablets contain a small amount of lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking No-Uric.</p><p>Taking other medicines :</p><p>Tell your doctor or pharmacist if you are taking any of the following:</p><p>- Aspirin.</p><p>- Theophylline, used for breathing problems.</p><p>- Medicines used for fits (epilepsy).</p><p>- Antibiotics.</p><p>- Didanosine, used to treat HIV infection.</p><p>- Medicines for cancer.</p><p>- Medicines used to reduce your immune response (immunosuppressants).</p><p>- Medicines used to treat diabetes.</p><p>- Medicines for heart problems or high blood pressure such as &#39;ACE inhibitors&#39; or water tablets (diuretics).</p><p>- Medicines used to thin your blood (anticoagulants),&nbsp; such as warfarin.</p><p>- Any other medicine to treat gout.</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because No-Uric can affect the way some medicines work. Also some other medicines can affect the way No-Uric works.</p><p>Taking No-Uric with food and drink:</p><p>Take No-Uric with food and water.</p><p>Pregnancy and breast-feeding:</p><p>Talk to your doctor before taking this medicine if you are pregnant, might become pregnant or are breast-feeding.</p><p>Driving and using machines:</p><p>You may feel drowsy, giddy or have problems with your co-ordination. If this happens. Do not drive or use any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take No-Uric exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Taking this medicine:</p><p>- Swallow the tablet with a drink of water.</p><p>- Take with or just after food.</p><p>Children (under 15 years): The usual dose ranges from 100 to 400 mg each day.</p><p>Adults (over 18 years): The usual dose ranges from 100 to 900 mg each day.</p><p>You will usually start on a dose of 100 to 300 mg each day.</p><p>Elderly (over 65 years): Your doctor will prescribe the lowest dose of No-Uric tablets that best controls your symptoms.</p><p>If you have a serious kidney problem:</p><p>- You may be asked to take less than 100 mg each day or you may be asked to take 100 mg at longer intervals than one day.</p><p>If you have dialysis two or three times a week. Your doctor may prescribe a dose of 300 or 400 mg which is to be taken straight after your dialysis.</p><p>If you take more No-Uric than you should:</p><p>If you take more No-Uric than you should, talk to a doctor or go to hospital straight away. Take the medicine pack with you.</p><p>If you forget to take No-Uric:</p><p>- If you forget a dose, take it as soon as you remember it.</p><p>However, if it is nearly time for the next dose, skip the missed dose.</p><p>- Do not take a double dose to make up for a forgotten dose.</p><p>If you stop taking No-Uric:</p><p>Do not stop taking your No-Uric without talking to your doctor.</p><p>If you have any further questions on the use of this product. Ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, No-Uric can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:&nbsp;</p><p>Allergic reactions (affects less than 1 in 10,000 people):</p><p>If you have an allergic reaction, stop taking No-Uric and see a doctor straight way. The signs may include:</p><p>- Skin rash, flaking skin, boils or sore lips and mouth.</p><p>- Very rarely signs may include sudden wheeziness, fluttering&nbsp; or tightness in the chest and collapse.</p><p>Do not take any more tablets unless your doctor tells you to do so.</p><p>If you experience any of the following, stop your tablets and tell your doctor as soon as possible:</p><p>Rare (affects less than 1 in 1000 people):</p><p>- Joint pain or painful swelling in your groin, armpits or neck.</p><p>- Yellowing of the skin and eyes jaundice.</p><p>- Iiver or kidney problems.</p><p>- Feeling sick (nausea) or being sick (vomiting), occasionally with blood.</p><p>- You notice any changes to your skin, for example blisters or peeling.</p><p>- Fever and chills, aching muscles and generally feeling unwell.</p><p>- Bleeding in the lips, eyes, mouth, nose or genitals.</p><p>Very rare (affects less than 1 in 10,000 people):</p><p>- Bruising more easily than usual, or you may develop a sore throat or other signs of an infection. Tell your doctor as soon as possible. Occasionally No-Uric tablets may affect your blood or lymph system. These effects usually occur in people with liver or kidney problems.</p><p>- High temperature.</p><p>- Blood in your urine (haematuria).</p><p>- High levels of cholesterol in your blood (hyperlipidaemia).</p><p>- A general feeling of being unwell.</p><p>- Weakness, numbness, unsteadiness on your feet, feeling unable to move muscles (paralysis) or loss of consciousness.</p><p>- Headache, dizziness, drowsiness or disturbance of your vision.</p><p>- Chest pain, high blood pressure or a slow pulse.</p><p>- Male infertility or erectile dysfunction.</p><p>- Enlargement of the breasts, in men as well as women.</p><p>- A change in your normal bowel habit.</p><p>- A change in taste.</p><p>- Cataracts.</p><p>- Hair loss or discolouration.</p><p>- Fits (convulsions).</p><p>- Depression.</p><p>- Build up of fluid leading to swelling (oedema) particularly of your ankles.</p><p>- Feeling thirsty, tired and losing weight; these may be symptoms of diabetes. Your doctor may wish to measure the level of sugar in your blood to check if this is happening.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.</p><p>- Do not use No-Uric after the expiry date which is stated on the carton after &#39;EXP&#39;. The expiry date refers to the last day of that month.</p><p>- Keep your tablets in the original packaging.</p><p>- Store at temperature not exceeding 30˚C.</p><p>- Medicines should not be disposed of via waste water or house hold waste.</p><p>- Return any unused or unwanted tablets to your pharmacist for disposal. Only keep them if your doctor tells you to. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What No-Uric tablets contain:</p><p>- The active substance (the ingredient that makes the tablets work) is Allopurinol.</p><p>Each tablet contains either 100 mg or 300 mg of allopurinol.</p><p>The inactive ingredients of No-Uric 100 mg tablets:</p><p>Colloidal silicon dioxide, sodium starch glycolate, maize starch, magnesium stearate, lactose, sodium benzoate.</p><p>The inactive ingredients of No-Uric 300 mg tablets:</p><p>Colloidal silicon dioxide, sodium starch glycolate, maize starch, magnesium stearate, lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                No- Uric 100 Tablets: Box of 5 strips of 10 tablets each.
No- Uric 300 Tablets: Box of 2 strips of 10 tablets each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Egyptian International Pharmaceutical Industries Company, E.I.P.I.CO.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                May 2010.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:right">إن نو - يوريك أقراص يحتوى على الوبيورينول. الذى يعمل على إبطاء سرعة بعض التفاعلات الكيميائية فى الجسم.</p><p dir="RTL" style="text-align:right">يستخدم نو - يوريك:</p><p dir="RTL" style="text-align:right">- لمنع الإصابة بمرض النقرس، حيث ينتج الجسم كمية كبيرة من حمض اليوريك. ثم يتراكم حمض اليوريك فى المفاصل والأوتار فى صورة بلورات. و ينتج عن تراكم هذه البلورات حدوث إلتهاب. إن الإلتهاب يجعل الجلد حول مفاصل معينة متورم، مؤلم و ضعيف عند لمسه فقط. و يمكن أن تشعر أيضا بألم شديد عند تحريك المفاصل.</p><p>- لمنع الإصابة بحالات أخرى نتيجة تراكم حمض اليوريك فى الجسم. و التى تشمل حصوات الكلى وغيرها من مشاكل الكلى و أثناء تلقى علاج لمرض السرطان.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">لا تأخذ نو - يوريك إذا كنت:</p><p dir="RTL" style="text-align:right">لديك حساسية (مفرطة) من الوبيورينول أو من أى من المكونات الأخرى بالمستحضر.</p><p dir="RTL" style="text-align:right">لا تأخذ نو - يوريك إذا كان مما سبق ينطبق عليك. و إذا كنت غير متأكد، تحدث إلى الطبيب أو الصيدلى&nbsp; قبل أخذ نو - يوريك.</p><p dir="RTL" style="text-align:right">يجب توخى الحذر عند أخذ نو - يوريك:</p><p dir="RTL" style="text-align:right">راجع الطبيب أو الصيدلى قبل تناول الدواء إذا كنت:</p><p dir="RTL" style="text-align:right">- لديك مشاكل فى الكبد أو الكلى. قد يعطيك طبيبك جرعة أقل أو قد يطلب منك خفض عدد مرات أخذ الدواء فى اليوم. كما سيراقبك أيضا عن كثب أكثر.</p><p dir="RTL" style="text-align:right">- لديك مشاكل فى القلب أو إرتفاع فى ضغط الدم.</p><p dir="RTL" style="text-align:right">- تواجه حاليا نوبة نقرس.</p><p dir="RTL" style="text-align:right">- قد قيل لك من قبل الطبيب أن لديك عدم تحمل لللاكتوز. حيث أن نو - يوريك أقراص يحتوى على كمية صغيرة من اللاكتوز. إذا قيل لك من قبل الطبيب أن لديك عدم تحمل لبعض السكريات، إتصل بطبيبك قبل أخذ هذا المنتج.</p><p dir="RTL" style="text-align:right">إذا كنت غير متأكد مما إذا كانت أى من الحالات السابقة تنطبق عليك، تحدث إلى الطبيب أو الصيدلى&nbsp; قبل اخذ نو - يوريك.</p><p dir="RTL" style="text-align:right">أخذ أدوية أخرى:</p><p dir="RTL" style="text-align:right">أخبر الطبيب أو الصيدلى إذا كنت تأخذ أى من الأدوية التالية:</p><p dir="RTL" style="text-align:right">- أسبرين.</p><p dir="RTL" style="text-align:right">- ثيوفيلين، المستخدم لعلاج مشاكل فى التنفس.</p><p dir="RTL" style="text-align:right">- الأدوية المضادة للنوبات (الصرع).</p><p dir="RTL" style="text-align:right">- المضادات الحيوية.</p><p dir="RTL" style="text-align:right">- ديدانوزين، المستخدم لعلاج الإصابة بفيروس نقص المناعة.</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة فى علاج السرطان.</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة لتقليل الإستجابة مناعية (مناعة).</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة لعلاج مرض السكر.</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة فى علاج مشاكل القلب أو إرتفاع ضغط الدم مثل مثبطات الإنزيم المحول للأنجيوتنسين أو أقراص الماء (مدرات البول).</p><p dir="RTL" style="text-align:right">- الأدوية المضادة لتجلط الدم مثل وارفارين.</p><p dir="RTL" style="text-align:right">- أى دواء آخر لعلاج النقرس.</p><p dir="RTL" style="text-align:right">يرجى إخبار الطبيب أو الصيدلى إذا كنت تأخذ أو أخذت فى الآونة الأخيرة أى أدوية أخرى. وتشمل الأدوية العشبية أو الأدوية الأخرى التى اشتريتها من دون وصفة طبية. وذلك لأن نو - يوريك يمكن أن يؤثر على طريقة عمل بعض الأدوية. كما يمكن لبعض الأدوية الأخرى أن تؤثر على طريقة عمل نو - يوريك.</p><p dir="RTL" style="text-align:right">عند أخذ الدواء مع الطعام والشراب:</p><p dir="RTL" style="text-align:right">خذ نو - يوريك مع الغذاء والماء.</p><p dir="RTL" style="text-align:right">الحمل والرضاعة الطبيعية:</p><p dir="RTL" style="text-align:right">تحدث مع طبيبك قبل أخذ هذا الدواء إذا كنت حاملا، قد تصبحين حاملا أو خلال فترة الرضاعة الطبيعية.</p><p dir="RTL" style="text-align:right">القيادة أو العمل أمام الماكينات:</p><p>قد تشعر بالنعاس، دوار أو بمشاكل فى التوازن. إذا حدث ذلك، يجب عليك عدم القيادة أو إستخدام أى أدوات أو آلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">يجب دائما تناول الدواء طبقا لتعليمات الطبيب. و إذا لم تكن متأكدا، إستشير الطبيب أو الصيدلى.</p><p dir="RTL" style="text-align:right">أخذ الدواء:</p><p dir="RTL" style="text-align:right">ابلع القرص مع شربة ماء.</p><p dir="RTL" style="text-align:right">خذ الدواء مع الطعام أو بعده.</p><p dir="RTL" style="text-align:right">للأطفال (تحت 15 عاما): تتراوح الجرعة المعتادة من 100 - 400 مجم كل يوم.</p><p dir="RTL" style="text-align:right">للبالغين (فوق 18 سنة): تتراوح الجرعة المعتادة من 100 - 900 مجم كل يوم.</p><p dir="RTL" style="text-align:right">إن الجرعة المبدئية تتراوح عادة من 100 - 300 مجم كل يوم.</p><p dir="RTL" style="text-align:right">لكبار السن (أكثر من 65 عاما): سوف يصف لك الطبيب أدنى جرعة تعطى أفضل سيطرة على الأعراض.</p><p dir="RTL" style="text-align:right">إذا كان لديك مشكلة خطيرة فى الكلى: قد يطلب منك الطبيب أن تأخذ جرعة أقل من 100 مجم يوميا. أو قد يطلب منك الطبيب أن تأخذ 100 مجم على فترات أطول من يوم واحد.</p><p dir="RTL" style="text-align:right">إذا كنت تقوم بعملية غسيل كلى مرتين أو ثلاث مرات فى الأسبوع، قد يصف لك الطبيب جرعة 300 أو 400 مجم تؤخذ مباشرة بعد الغسيل.</p><p dir="RTL" style="text-align:right">عند تناول جرعة أكبر من المطلوب:</p><p dir="RTL" style="text-align:right">إذا أخذت جرعة أكبر من الجرعة الموصوفة لك، تحدث إلى الطبيب أو إذهب إلى أقرب مستشفى على الفور. و خذ معك العبوة و ما تبقي بها من أقراص حتى يعلم الأطباء ما أخذته.</p><p dir="RTL" style="text-align:right">عند نسيان تناول إحدى الجرعات:</p><p dir="RTL" style="text-align:right">إذا نسيت تناول جرعة فى الوقت المناسب، خذ الجرعة فور تذكرها. إذا كان موعد الجرعة التالية قد إقترب لا تأخذ الجرعة المنسية.</p><p dir="RTL" style="text-align:right">لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL" style="text-align:right">عند التوقف عن تناول الدواء:</p><p dir="RTL" style="text-align:right">لا تتوقف عن أخذ الدواء إلا بعد إستشارة الطبيب.</p><p>إذا كان لديك أى أسئلة أخرى عن كيفية إستخدام هذا الدواء، إسأل طبيبك أو الصيدلى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">مثل جميع الأدوية، يمكن أن يسبب نو - يوريك بعض الأعراض الجانبية، بالرغم من أنه ليس علي جميع المرضي الإصابة بهذه الأعراض.</p><p dir="RTL" style="text-align:right">تفاعلات الحساسية (تؤثر على أقل من شخص فى كل 10000 شخص):</p><p dir="RTL" style="text-align:right">إذا ظهرت عليك تفاعلات حساسية، توقف عن أخذ نو - يوريك و إذهب إلى الطبيب على الفور. قد تشمل الأعراض:</p><p dir="RTL" style="text-align:right">- طفح جلدى، تساقط الجلد، دمامل أو تقرحات فى الشفتين والفم.</p><p dir="RTL" style="text-align:right">- نادرا جدا يمكن أن يحدث أزيز مفاجئ عند التنفس، رعشة أو ضيق فى الصدر و إنهيار.</p><p dir="RTL" style="text-align:right">لا تأخذ أى أقراص أخرى حتى يخبرك طبيبك بذلك.</p><p dir="RTL" style="text-align:right">إذا كنت تواجه أى من الأعراض الجانبية التالية، توقف عن أخذ الدواء و أخبر الطبيب فى أقرب وقت ممكن:</p><p dir="RTL" style="text-align:right">أعراض جانبية نادرة (تؤثر على أقل من شخص فى كل 1000 شخص):</p><p dir="RTL" style="text-align:right">- آلام المفاصل أو تورم مؤلم فى الإبط، الفخذ أو الرقبة.</p><p dir="RTL" style="text-align:right">- إصفرار الجلد والعينين (يرقان).</p><p dir="RTL" style="text-align:right">- مشاكل فى الكبد أو الكلى.</p><p dir="RTL" style="text-align:right">- غثيان أو القىء، وأحيانا مع دم.</p><p dir="RTL" style="text-align:right">- قد تلاحظ تغيرات فى جلدك، مثل ظهور بثور أو تقشير.</p><p dir="RTL" style="text-align:right">- حمى، قشعريرة، ألم فى العضلات و شعور عام بالإعياء.</p><p dir="RTL" style="text-align:right">- نزيف بالشفتين، العينين، الأنف، الفم أو الأعضاء التناسلية.</p><p dir="RTL" style="text-align:right">أعراض جانبية نادرة جدا (تؤثر على أقل من شخص فى كل 10000 شخص):</p><p dir="RTL" style="text-align:right">- كدمات بسهولة أكثر من المعتاد، أو قد تصاب بإلتهاب بالحلق أو غيرها من علامات العدوى. أخبر طبيبك فى أقرب وقت ممكن. أحيانا قد يؤثر نو - يوريك على الدم أو الجهاز الليمفاوى. و هذه الأعراض عادة ما تحدث فى الأشخاص الذين يعانون من مشاكل فى الكبد أو الكلى.</p><p dir="RTL" style="text-align:right">- إرتفاع فى درجة حرارة الجسم.</p><p dir="RTL" style="text-align:right">- ظهور دم فى البول.</p><p dir="RTL" style="text-align:right">- زيادة مستوى الكولسترول فى الدم.</p><p dir="RTL" style="text-align:right">- شعور عام بالمرض.</p><p dir="RTL" style="text-align:right">- ضعف، تنميل، صعوبة فى الثبات على قدميك، شعور بعدم القدرة على تحريك العضلات (شلل) أو فقدان الوعى.</p><p dir="RTL" style="text-align:right">- صداع، دوخة، نعاس أو اضطراب فى الرؤية.</p><p dir="RTL" style="text-align:right">- ألم فى الصدر، إرتفاع فى ضغط الدم أو نبض بطىء.</p><p dir="RTL" style="text-align:right">- العقم عند الذكور أو عدم القدرة على الإنتصاب.</p><p dir="RTL" style="text-align:right">- تضخم الثدى فى الرجال مثل النساء.</p><p dir="RTL" style="text-align:right">- تغير فى حركة الأمعاء الطبيعية.</p><p dir="RTL" style="text-align:right">- تغير فى حاسة التذوق.</p><p dir="RTL" style="text-align:right">- مياة زرقاء بالعين.</p><p dir="RTL" style="text-align:right">- فقدان الشعر أو تغير لونه.</p><p dir="RTL" style="text-align:right">- نوبات (تشنجات).</p><p dir="RTL" style="text-align:right">- إكتئاب.</p><p dir="RTL" style="text-align:right">- تراكم السوائل التى تؤدى إلى تورم (أوديما) الكاحلين.</p><p dir="RTL" style="text-align:right">- شعور بالعطش، تعب وفقدان الوزن؛ قد تكون هذه أعراض مرض السكر. لذلك قد يرغب طبيبك فى قياس مستوى السكر فى الدم لمعرفة ما إذا كانت أعراض سكر أم لا.</p><p>يجب إخبار الطبيب أو الصيدلى فور ملاحظة أن الأعراض الجانبية تزداد سوءا أو عند حدوث أعراض جانبية غير مسجلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">يحفظ فى درجة حرارة لا تزيد عن 30 &ordm; م.</p><p dir="RTL" style="text-align:right">يحفظ الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL" style="text-align:right">يجب عدم تعاطى نو - يوريك بعد إنتهاء تاريخ الصلاحية المكتوب على العلبة، و يشير تاريخ إنتهاء الصلاحية إلى آخر يوم فى الشهر المذكور.</p><p>يجب عدم التخلص من الدواء عن طريق مياة المجارى أو عن طريق القمامة. و يجب إستشارة الصيدلى&nbsp; عن كيفية التخلص من الدواء غير المستخدم، و الهدف من ذلك المحافظة على البيئة نظيفة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">المادة الفعالة: اللوبيورينول</p><p dir="RTL" style="text-align:right">كل قرص يحتوى على 100 أو 300 مجم الوبيورينول&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL" style="text-align:right">المواد غير الفعالة فى نو &ndash; يوريك 100 مجم:</p><p dir="RTL" style="text-align:right">ثانى أوكسيد السيليكون الغروانى، نشا جليكولات الصوديوم، نشا ذرة، ماغنسيوم ستيريت، لاكتوز و بنزوات الصوديوم.</p><p dir="RTL" style="text-align:right">المواد غير الفعالة فى نو &ndash; يوريك 300 مجم:</p><p dir="RTL" style="text-align:right">ثانى أوكسيد السيليكون الغروانى، نشا جليكولات الصوديوم، نشا ذرة، ماغنسيوم ستيريت، لاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">العبوة:</p><p dir="RTL" style="text-align:right">نو &ndash; يوريك 100 مجم: علبة بها 5 شرائط بكل منها 10 أقراص.</p><p>نو &ndash; يوريك 300 مجم: علبة بها&nbsp; شريطين بكل منها 10 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة المصرية الدولية للصناعات الدوائية (إيبيكو)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مايو 2010.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                No-Uric 300 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet Contains:
Active Ingredient:
Allopurinol 300 mg
Inactive ingredients:
Colloidal silicon dioxide, Maize starch, Lactose Monohydrate ,Sodium starch glycolate & Magnesium stearate.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No-Uric is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis) or is a predictable clinical risk (e.g. treatment of malignancy potentially leading to acute uric acid<br />nephropathy). The main clinical conditions where urate/uric acid deposition may occur are:<br />idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate levels occur either spontaneously, or after cytotoxic therapy; certain enzyme disorders which lead to overproduction of urate, for example: hypoxanthine-guanine phosphoribosyltransferase, including Lesch-Nyhan syndrome; glucose-6-phosphatase including glycogen storage disease; phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase; adenine phosphoribosyltransferase.<br />No-Uric is indicated for management of 2,8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity of adenine phosphoribosyltransferase.<br />No-Uric is indicated for the management of recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria, when fluid, dietary and similar measures have failed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage in Adults:<br />No-Uric should be introduced at low dosage e.g. 100mg/day to reduce the risk of adverse reactions and increased only if the serum urate response is unsatisfactory. Extra caution should be exercised if renal function is poor. The following dosage schedules are suggested:<br />100 to 200 mg daily in mild conditions,<br />300 to 600 mg daily in moderately severe conditions,<br />700 to 900 mg daily in severe conditions.<br />If dosage on a mg/kg bodyweight basis is required, 2 to 10 mg/kg bodyweight/day should be used.<br />Dosage in children:<br />Children under 15 years: 10 to 20 mg/kg bodyweight/day up to a maximum of 400 mg daily.<br />Use in children is rarely indicated, except in malignant conditions (especially leukaemia) and certain enzyme disorders such as Lesch-Nyhan syndrome.<br />Dosage in the elderly:<br />In the absence of specific data, the lowest dosage which produces satisfactory urate reduction should be used. Particular attention should be paid to advice in Dosage in renal impairment and Precautions and Warnings.<br />Dosage in renal impairment:<br />Since allopurinol and its metabolites are excreted by the kidney, impaired renal function may lead to retention of the drug and/or its metabolites with consequent prolongation of plasma half-lives. In severe renal insufficiency, it may be advisable to use less than 100 mg per day or to use single doses of 100mg at longer intervals than one day.<br />If facilities are available to monitor plasma oxipurinol concentrations, the dose should be adjusted to maintain plasma oxipurinol levels below 100 micromol/litre (15.2 mg/litre).<br />Allopurinol and its metabolites are removed by renal dialysis. If dialysis is required two to three times a week consideration should be given to an alternative dosage schedule of 300-400 mg No-Uric immediately after each dialysis with none in the interim.<br />Dosage in hepatic impairment:<br />Reduced doses should be used in patients with hepatic impairment. Periodic liver function tests are recommended during the early stages of therapy.<br />Treatment of high urate turnover conditions, e.g. neoplasia, Lesch-Nyhan syndrome: It is advisable to correct existing hyperuricaemia and/or hyperuricosuria with No-Uric before starting cytotoxic therapy. It is important to ensure adequate hydration to maintain optimum diuresis and to attempt alkalinisation of urine to increase solubility of urinary urate/uric acid.<br />Dosage of No-Uric should be at the lower end of the recommended dosage schedule.<br />If urate nephropathy or other pathology has compromised renal function, the advice given in<br />Dosage in renal impairment should be followed.<br />These steps may reduce the risk of xanthine and/or oxipurinol deposition complicating the clinical situation.<br />Monitoring Advice:<br />The dosage should be adjusted by monitoring serum urate concentrations and urinary urate/uric acid levels at appropriate intervals.<br />Instructions for Use: No-Uric may be taken orally once a day after a meal. It is well tolerated, especially after food. Should the daily dosage exceed 300 mg and gastrointestinal intolerance be manifested, a divided doses regimen may be appropriate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                No-Uric should not be administered to individuals known to be hypersensitive to allopurinol or to any of the components of the formulation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No-Uric should be withdrawn immediately when a skin rash or other evidence of sensitivity occurs as this could result in more serious hypersensitivity reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis) (see Adverse Reactions &ndash; Immune system disorders and Skin and subcutaneous tissue disorders).<br />Reduced doses should be used in patients with hepatic or renal impairment. Patients under treatment for hypertension or cardiac insufficiency, for example with diuretics or ACE inhibitors, may have some concomitant impairment of renal function and allopurinol should be used with care in this group.<br />Asymptomatic hyperuricaemia per se is generally not considered an indication for use of No-Uric.Fluid and dietary modification with management of the underlying cause may correct the condition.<br />Acute gouty attacks: Allopurinol treatment should not be started until an acute attack of gout has completely subsided, as further attacks may be precipitated.<br />In the early stages of treatment with No-Uric, as with uricosuric agents, an acute attack of gouty arthritis may be precipitated. Therefore it is advisable to give prophylaxis with a suitable anti-inflammatory agent or colchicine for at least one month. The literature should be consulted for details of appropriate dosage and precautions and warnings.<br />If acute attacks develop in patients receiving allopurinol, treatment should continue at the same dosage while the acute attack is treated with a suitable anti-inflammatory agent.<br />Xanthine deposition: In conditions where the rate of urate formation is greatly increased (e.g. malignant disease and its treatment, Lesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in rare cases, rise sufficiently to allow deposition in the urinary tract.<br />This risk may be minimised by adequate hydration to achieve optimal urine dilution.<br />Impaction of uric acid renal stones: Adequate therapy with No-Uric will lead to dissolution of large uric acid renal pelvic stones, with the remote possibility of impaction in the ureter.<br />Lactose intolerance: No-Uric tablets contain lactose and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>6 -mercaptopurine and azathioprine:<br />Azathioprine is metabolised to 6-mercaptopurine which is inactivated by the action of xanthine oxidase. When 6-mercaptopurine or azathioprine is given concurrently with No-Uric, only one-quarter of the usual dose of 6-mercaptopurine or azathioprine should be given<br />because inhibition of xanthine oxidase will prolong their activity.<br />Vidarabine (Adenine Arabinoside):<br />Evidence suggests that the plasma half-life of vidarabine is increased in the presence of allopurinol. When the two products are used concomitantly extra vigilance is necessary, to recognise enhanced toxic effects.<br />Salicylates and uricosuric agents:<br />oxipurinol, the major metabolite of allopurinol and itself therapeutically active, is excreted by the kidney in a similar way to urate. Hence, drugs with uricosuric activity such as probenecid or large doses of salicylate may accelerate the excretion of oxipurinol. This may decrease the<br />therapeutic activity of No-Uric, but the significance needs to be assessed in each case.</p><p>Chlorpropamide:<br />If No-Uric is given concomitantly with chlorpropamide when renal function is poor, there may be an increased risk of prolonged hypoglycaemic activity because allopurinol and chlorpropamide may compete for excretion in the renal tubule.<br />Coumarin anticoagulants<br />There have been rare reports of increased effect of warfarin and other coumarin anticoagulants when co-administered with allopurinol, therefore, all patients receiving anticoagulants must be carefully monitored.<br />Phenytoin:<br />Allopurinol may inhibit hepatic oxidation of phenytoin but the clinical significance has not been demonstrated.<br />Theophylline: Inhibition of the metabolism of theophylline has been reported. The mechanism of the interaction may be explained by xanthine oxidase being involved in the biotransformation of theophylline in man. Theophylline levels should be monitored in patients starting or increasing allopurinol therapy.<br />Ampicillin/Amoxicillin:<br />An increase in frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs. The cause of the reported association has not been established. However, it is recommended that in patients receiving allopurinol an alternative to ampicillin or amoxicillin is used where available.<br />Cyclophosphamide, doxorubicin, bleomycin, procarbazine, mechloroethamine:<br />Enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease (other than leukaemia), in the presence of allopurinol. However, in a well-controlled study of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechloroethamine (chlormethine hydrochloride) allopurinol did not appear to increase the toxic reaction of these cytotoxic agents.</p><p>Ciclosporin:<br />Reports suggest that the plasma concentration of ciclosporin may be increased during concomitant treatment with allopurinol. The possibility of enhanced ciclosporin toxicity should be considered if the drugs are co-administered.<br />Didanosine:<br />In healthy volunteers and HIV patients receiving didanosine, plasma didanosine Cmax and AUC values were approximately doubled with concomitant allopurinol treatment (300 mg daily) without affecting terminal half life. Co-administration of these 2 drugs is generally not recommended. If concomitant use is unavoidable, a dose reduction of didanosine may be required, and patients should be closely monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is inadequate evidence of safety of No-Uric in human pregnancy, although it has been in wide use for many years without apparent ill consequence.<br />Use in pregnancy only when there is no safer alternative and when the disease itself carries risk for the mother or unborn child.<br />Reports indicate that allopurinol and oxipurinol are excreted in human breast milk.<br />Concentrations of 1.4mg/litre allopurinol and 53.7 mg/litre oxipurinol have been demonstrated in breast milk from woman taking No-Uric 300 mg/day. However, there are no data concerning the effects of allopurinol or its metabolites on the breast-fed baby.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Since adverse reactions such as somnolence, vertigo and ataxia have been reported in patients receiving allopurinol, patients should exercise caution before driving, using machinery or participating in dangerous activities until they are reasonably certain that allopurinol does not adversely affect performance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For this product there is no modern clinical documentation which can be used as support for determining the frequency of undesirable effects. Undesirable effects may vary in their incidence depending on the dose received and also when given in combination with other therapeutic agents.</p><p>The frequency categories assigned to the adverse drug reactions below are estimates: for most reactions, suitable data for calculating incidence are not available. Adverse drug reactions identified through post-marketing surveillance were considered to be rare or very rare.<br />The following convention has been used for the classification of frequency:<br />Very common (&ge;1/10 (&ge;10%)<br />Common (&ge;1/100 and &lt;1/10 (&ge;1% and &lt;10%)<br />Uncommon (&ge;1/1000 and &lt;1/100 (&ge;0.1% and &lt;1%)<br />Rare (&ge;1/10,000 and &lt;1/1000 (&ge;0.01% and &lt;0.1%)<br />Very rare (&lt;1/10,000 (&lt;0.01%)<br />Adverse reactions in association with No-Uric are rare in the overall treated population and mostly of a minor nature. The incidence is higher in the presence of renal and/or hepatic disorder.<br />Infections and infestations<br />Very rare: Furunculosis<br />Blood and lymphatic system disorders<br />Very rare: Agranulocytosis, aplastic anaemia, thrombocytopenia<br />Very rare reports have been received of thrombocytopenia, agranulocytosis and aplastic anaemia, particularly in individuals with impaired renal and/or hepatic function, reinforcing the need for particular care in this group of patients.<br />Immune system disorders<br />Uncommon: Hypersensitivity reactions<br />Very rare: Angioimmunoblastic lymphadenopathy<br />Serious hypersensitivity reactions, including skin reactions associated with exfoliation, fever, lymphadenopathy, arthralgia and/or eosinophilia including Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis occur rarely.Associated vasculitis and tissue response may be manifested in various ways including hepatitis, renal impairment and very rarely, seizures.<br />Very rarely acute anaphylactic shock has been reported. If such reactions do occur, it may be at any time during treatment, No-Uric should be withdrawn immediately and permanently.<br />Corticosteroids may be beneficial in overcoming hypersensitivity skin reactions. When generalised hypersensitivity reactions have occurred, renal and/or hepatic disorder has usually been present particularly when the outcome has been fatal.<br />Angioimmunoblastic lymphadenopathy has been described very rarely following biopsy of a generalised lymphadenopathy. It appears to be reversible on withdrawal of No-Uric.<br />Metabolism and nutrition disorders</p><p>Very rare: Diabetes mellitus, hyperlipidaemia<br />Psychiatric disorders<br />Very rare: Depression<br />Nervous system disorders<br />Very rare: Coma, paralysis, ataxia, neuropathy, paraesthesiae, somnolence, headache, taste perversion<br />Eye disorders<br />Very rare: Cataract, visual disorder, macular changes<br />Ear and labyrinth disorders<br />Very rare: Vertigo<br />Cardiac disorders<br />Very rare: Angina, bradycardia<br />Vascular disorders<br />Very rare: Hypertension<br />Gastrointestinal disorders<br />Uncommon: Vomiting, nausea<br />Very rare: Recurrent haematemesis, steatorrhoea, stomatitis, changed bowel habit<br />In early clinical studies, nausea and vomiting were reported. Further reports suggest that this reaction is not a significant problem and can be avoided by taking No-Uric after meals.<br />Hepatobiliary disorders<br />Uncommon: Asymptomatic increases in liver function tests<br />Rare: Hepatitis (including hepatic necrosis and granulomatous hepatitis)<br />Hepatic dysfunction has been reported without overt evidence of more generalised hypersensitivity.<br />Skin and subcutaneous tissue disorders<br />Common: Rash<br />Rare: Stevens-Johnson syndrome/toxic epidermal necrolysis<br />Very rare: Angioedema, fixed drug eruption, alopecia, discoloured hair<br />Skin reactions are the most common reactions and may occur at any time during treatment.<br />They may be pruritic, maculopapular, sometimes scaly, sometimes purpuric and rarely exfoliative, such as Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).<br />No-Uric should be withdrawn immediately should such reactions occur. After recovery from mild reactions, No-Uric may, if desired, be re-introduced at a small dose (e.g. 50mg/day) and gradually increased. If the rash recurs, No-Uric should be permanently withdrawn as more severe hypersensitivity may occur.<br />The HLA-B*5801 allele has been has been identified as a genetic risk factor for allopurinol associated SJS/TEN in retrospective, case-control, pharmacogenetic studies in patients of Han Chinese, Japanese and European descent. Up to 20-30% of some Han Chinese, African and<br />Indian populations carry the HLA-B*5801 allele whereas only 1-2% of Northern European, US European and Japanese patients are estimated to be HLA-B*5801 carriers. However, the use of genotyping as a screening tool to make decisions about treatment with allopurinol has not been established.<br />The clinical diagnosis of SJS/TEN remains the basis for decision making. If such reactions occur at any time during treatment, allopurinol should be withdrawn immediately and permanently.<br />Angioedema has been reported to occur with and without signs and symptoms of a more generalised hypersensitivity reaction.<br />Renal and urinary disorders<br />Very rare: Haematuria, uraemia<br />Reproductive system and breast disorders<br />Very rare: Male infertility, erectile dysfunction, gynaecomastia<br />General disorders and administration site conditions<br />Very rare: Oedema, general malaise, asthenia, fever<br />Fever has been reported to occur with and without signs and symptoms of a more generalised No-Uric hypersensitivity reaction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ingestion of up to 22.5 g allopurinol without adverse effect has been reported. Symptoms and signs including nausea, vomiting, diarrhoea and dizziness have been reported in a patient who ingested 20 g allopurinol. Recovery followed general supportive measures. Massive absorption of No-Uric may lead to considerable inhibition of xanthine oxidase activity, which should have no untoward effects unless affecting concomitant medication, especially with 6-mercaptopurine and/or azathioprine. Adequate hydration to maintain optimum diuresis facilitates excretion of allopurinol and its metabolites. If considered necessary haemodialysis may be used.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group xanthine-oxidase inhibitor.<br />ATC Code: M04AA01.<br />Allopurinol is a xanthine-oxidase inhibitor. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid. In addition to the inhibition of purine catabolism in some but not all hyperuricaemic patients, de novo purine biosynthesis is depressed via feedback inhibition of hypoxanthine-guanine phosphoribosyltransferase. Other metabolites of allopurinol include allopurinol-riboside and oxipurinol-7 riboside.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Allopurinol is active when given orally and is rapidly absorbed from the upper gastrointestinal tract. Studies have detected allopurinol in the blood 30-60 minutes after dosing. Estimates of bioavailability vary from 67% to 90%. Peak plasma levels of allopurinol generally occur approximately 1.5 hours after oral administration of No-Uric, but fall rapidly and are barely detectable after 6 hours. Peak levels of oxipurinol generally occur after 3-5 hours after oral administration of No-Uric and are much more sustained.<br />Allopurinol is negligibly bound by plasma proteins and therefore variations in protein binding are not thought to significantly alter clearance. The apparent volume of distribution of allopurinol is approximately 1.6 litre/kg which suggests relatively extensive uptake by tissues. Tissue concentrations of allopurinol have not been reported in humans, but it is likely that allopurinol and oxipurinol will be present in the highest concentrations in the liver and<br />intestinal mucosa where xanthine oxidase activity is high.<br />Approximately 20% of the ingested allopurinol is excreted in the faeces. Elimination of allopurinol is mainly by metabolic conversion to oxipurinol by xanthine oxidase and aldehyde oxidase, with less than 10% of the unchanged drug excreted in the urine.<br />Allopurinol has a plasma half-life of about 1 to 2 hours.<br />Oxipurinol is a less potent inhibitor of xanthine oxidase than allopurinol, but the plasma halflife of oxipurinol is far more prolonged. Estimates range from 13 to 30 hours in man.<br />Therefore effective inhibition of xanthine oxidase is maintained over a 24 hour period with a single daily dose of No-Uric. Patients with normal renal function will gradually accumulate oxipurinol until a steady-state plasma oxipurinol concentration is reached. Such patients, taking 300 mg of allopurinol per day will generally have plasma oxipurinol concentrations of 5-10 mg/litre.<br />Oxipurinol is eliminated unchanged in the urine but has a long elimination half-life because it undergoes tubular reabsorption. Reported values for the elimination half-life range from 13.6 hours to 29 hours. The large discrepancies in these values may be accounted for by variations in study design and/or creatinine clearance in the patients.<br />Pharmacokinetics in patients with renal impairment.<br />Allopurinol and oxipurinol clearance is greatly reduced in patients with poor renal function resulting in higher plasma levels in chronic therapy. Patients with renal impairment, where creatinine clearance values were between 10 and 20ml/min, showed plasma oxipurinol concentrations of approximately 30mg/litre after prolonged treatment with 300 mg allopurinol per day. This is approximately the concentration which would be achieved by doses of 600 mg/day in those with normal renal function. A reduction in the dose of No-Uric is therefore required in patients with renal impairment.<br />Pharmacokinetics in elderly patients.<br />The kinetics of the drug are not likely to be altered other than due to deterioration in renal function.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1: JAMA. 1975 Mar 17;231(11):1143-7. Links<br />Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose.<br />Rodnan GP, Robin JA, Tolchin SF, Elion GB.<br />The effect of daily administration of a single 300-mg tablet of allopurinol on serum urate levels was compared with the effect of divided doses of the drug (100 mg three times a day) in an open-labeled crossover trial of 20 patients with hyperuricemia and gout. Under both regimens of treatment there was a prompt fall in serum urate levels, and analysis of variance indicated no significant difference between the two modes of administration of allopurinol. Nor was there any significant difference in the minimum serum levels of oxypurinol. On the basis of this short-term study, the use of<br />a single 300-mg tablet of allopurinol per day appears to be an effective means of lowering the elevated serum urate levels of individuals with gouty hyperuricemia and compares favorably with the results obtained by allopurinol in divided doses.<br />PMID: 1172813 [PubMed - indexed for MEDLINE]</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Colloidal silicon dioxide, Maize starch, Lactose Monohydrate ,Sodium starch glycolate &amp; Magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablets stored at temp. not exceeding 30&ordm; C.<br />This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carton box containing two blisters each of 10 tablets and pamphlet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Egyptian International Pharmaceutical Industries Company, E.I.P.I.CO.,Egypt
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2011.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>